Ardan Equity

Founded in 2018, Ardan Equity specializes in middle-market buyouts within the healthcare and life sciences software and data sector. The firm collaborates with founders and management teams to accelerate growth and create market-leading platforms.

Paul Bleicher Ph.D

Executive Partner

Drew Boston

Founding Partner

5 past transactions

MMIT

Private Equity Round in 2021
Formularies from P&T to point of care: MMIT brings transparency and guidance to pharmacy and medical benefit information. Payers, pharmaceutical companies, providers and pharmacies use our data and workflow app to provide clarity from P&T to the point of care, ensuring consistent managed care decisions across the healthcare market.

WellSky

Private Equity Round in 2020
WellSky offers comprehensive software solutions and services across the entire healthcare continuum. Its products address complex healthcare challenges, enhance collaboration for growth, and enable better outcomes through predictive insights.

HealthEdge Software

Private Equity Round in 2020
HealthEdge provides a modern suite of products, HealthRules, built on patented technology. It enables healthcare payors to innovate, reduce costs, and improve outcomes by connecting everyone in the healthcare delivery cycle.

Intelerad Medical Systems

Private Equity Round in 2020
Intelerad provides medical imaging business solutions and services for radiology groups, hospitals, imaging centers, and teleradiology businesses. Its software platform specializes in medical imaging, distributed radiology services, workflow orchestration, and radiology modules, helping clients improve productivity and streamline medical imaging workflows.

CorEvitas

Private Equity Round in 2019
CorEvitas is a provider of clinical registry data and analytics services focused on the biopharmaceutical sector. Established in 2000 and headquartered in Waltham, Massachusetts, the company specializes in delivering real-world evidence through its extensive registry data, which includes insights on patient experiences and outcomes. CorEvitas operates six autoimmune registries across the United States, Canada, and Japan, collecting data from over 400 participating investigator sites. The company ensures the accuracy and completeness of its data through rigorous quality control processes before it is stored in a secure data warehouse. Additionally, CorEvitas conducts active safety surveillance to support regulatory commitments for new drug approvals, contributing to post-authorization safety studies. The company's mission is to advance patient care and improve treatment through comprehensive real-world data analysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.